Background: Despite improvements in survival with current therapies, it is now clear that
major cardiovascular event rates in patients remain high. Cardiac cell replacement therapy …

The therapeutic use of stem cells for cardiac repair following myocardial infarction (MI) has
generated a great deal of interest. Many types of stem/progenitor cells have been used in an …

Regenerative medicine is a new biomedicine discipline that takes advantage of the recent
advancements in the fields of stem cell biology, molecular biology, and tissue engineering to …

Despite the well-documented capacity of embryonic stem cells (ESCs) to differentiate into
cardiomyocytes, transplantation of ESCs or ESC-derived cells is plagued by several …

Embryonic stem cells pace the heart | Nature Biotechnology Skip to main content Thank you
for visiting nature.com. You are using a browser version with limited support for CSS. To obtain …

© Translational Pediatrics. All rights reserved. Transl Pediatr 2016; 5 (3): 109-111 tp.
amegroups. com patients yet unborn. What are some of the future directions which research …

Fetal hypoplastic left heart syndrome (HLHS) is a severe congenital heart disease with a
lethal prognosis without postnatal therapeutic intervention or surgery. The aim of this article …

Stem cell-based therapies hold promise for regenerating the myocardium after injury.
Recent data obtained from phase I clinical trials using endogenous cardiovascular …

Cardiovascular disease is the leading cause of death in developed countries and is one of
the leading causes of disease burden in developing countries. Therapies have markedly …

Due to the limited proliferation capacity of cardiac cells, cell replacement therapy has been
proposed to restore cardiac function in patients suffering from ischemic heart disease and …